Pharmacological modulation of the late eosinophilia induced by antigen in actively sensitized rats

Int Arch Allergy Immunol. 1992;98(4):355-60. doi: 10.1159/000236211.

Abstract

The intrathoracic injection of ovalbumin (12 micrograms/cavity) into actively sensitized rats led to a long-lasting eosinophil recruitment, which appeared 24 h after stimulation. In this study, pharmacological antagonists were used in order to evaluate the potential involvement of arachidonic acid metabolites and PAF-acether in the pleural eosinophil accumulation by antigen. Administration of the cyclooxygenase inhibitor indomethacin (2 mg/kg, i.p.), 1 h before the antigen challenge, failed to modify the 24-hour eosinophilia. In contrast, the dual cyclooxygenase and lipoxygenase inhibitor BW 755C and the more selective inhibitor BW A4C (5 and 10 micrograms/cavity, i.t.), injected 1 h before the antigen, were effective. Similarly, the PAF-acether antagonists BN 52021 and WEB 2086 (20 mg/kg, i.p.) abrogated the eosinophil accumulation, which was also sensitive to the topical treatment with the glucocorticoid dexamethasone (5 and 10 micrograms/cavity). Our findings suggest that the antigen-induced eosinophil mobilization is dependent on lipoxygenase derivatives and PAF-acether, but not on prostaglandins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens / immunology
  • Arachidonic Acid / metabolism*
  • Cyclooxygenase Inhibitors / pharmacology
  • Eosinophilia / immunology*
  • Eosinophilia / metabolism
  • Female
  • Leukocyte Count
  • Lipoxygenase Inhibitors / pharmacology
  • Male
  • Ovalbumin / immunology
  • Platelet Activating Factor / antagonists & inhibitors
  • Platelet Activating Factor / physiology*
  • Pleurisy / immunology
  • Rats
  • Rats, Wistar

Substances

  • Antigens
  • Cyclooxygenase Inhibitors
  • Lipoxygenase Inhibitors
  • Platelet Activating Factor
  • Arachidonic Acid
  • Ovalbumin